healthNewsغير مصنف

Canada’s FSD Pharma to buy Israeli medical cannabis firm Therapix

Canada’s FSD Pharma Inc signed a letter of intent to acquire Israel’s Therapix Biosciences Ltd for $48 million in stock, combining two complementary businesses focused on the research and development of cannabinoid treatments.

اظهر المزيد

مقالات ذات صلة

زر الذهاب إلى الأعلى